首页 > 最新文献

Rambam Maimonides Medical Journal最新文献

英文 中文
CRISPR Technology: A Jewish Legal Perspective. CRISPR技术:犹太法律视角。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-27 DOI: 10.5041/RMMJ.10487
John D Loike, Rabbi Tzvi Flaum

Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future.

聚集规律间隔短回文重复序列(CRISPR)基因编辑是一种创新的、可能改变游戏规则的生物技术,可以以组织特异性的方式逆转DNA突变。此外,CRISPR还被用于异种移植、延长人类寿命、动物育种和植物科学。然而,CRISPR技术带来了许多伦理挑战。本文从犹太法律的角度讨论了与这些伦理挑战相关的几个立场。此外,我们还提出了CRISPR技术的其他几个应用,这些应用缺乏明确的犹太法律先例,需要拉比学者在未来解决和解决。
{"title":"CRISPR Technology: A Jewish Legal Perspective.","authors":"John D Loike,&nbsp;Rabbi Tzvi Flaum","doi":"10.5041/RMMJ.10487","DOIUrl":"https://doi.org/10.5041/RMMJ.10487","url":null,"abstract":"<p><p>Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"13 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40692860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary Prevention of Osteoporosis: If Not Now, When? 骨质疏松的二级预防:如果不是现在,什么时候?
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-31 DOI: 10.5041/RMMJ.10478
Tzvi Dwolatzky
EDITORIAL: The time has come for us to work together in a concerted effort to decrease the related suffering and consequences of osteoporotic fractures. And if not now, when?
{"title":"Secondary Prevention of Osteoporosis: If Not Now, When?","authors":"Tzvi Dwolatzky","doi":"10.5041/RMMJ.10478","DOIUrl":"https://doi.org/10.5041/RMMJ.10478","url":null,"abstract":"EDITORIAL: The time has come for us to work together in a concerted effort to decrease the related suffering and consequences of osteoporotic fractures. And if not now, when?","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40688916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Antibacterial Action of Safranin and Gentian Violet. 红花素和龙胆紫的抑菌作用。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-31 DOI: 10.5041/RMMJ.10475
Falah Al-Khikani, Aalae Ayit

Background: The increasing resistance of many bacterial pathogens against antibiotic measures urgently requires new or repurposing therapeutic strategies. Gentian violet is a triarylmethane dye used as a histological stain and for Gram's method of classifying bacteria. It also exerts an antimicrobial effect against certain pathogens, especially dermatological infections. Safranin is the most popular counterstain used in medical laboratories due to its low cost and safe laboratory usage. However, few studies have been conducted on the antimicrobial activity of safranin.

Objective: With the growing prevalence of multidrug-resistant bacteria, this study aimed to evaluate the antibacterial efficacy of gentian violet and safranin against multidrug-resistant Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa).

Methods: All tested bacteria were multidrug-resistant (MDR) bacteria isolated from skin infections (abscesses and wounds). Using gentian violet and safranin, antibacterial effects were studied using the well-diffusion method against 20 samples of clinically isolated bacteria, 10 diagnosed as S. aureus, and 10 as P. aeruginosa. Bacteria were diagnosed using the VITEK 2 automated system (bioMérieux, Marcy-l'Étoile, France). Iodine served as the control agent, since both Gram-positive and Gram-negative bacteria are sensitive to it.

Results: Gentian violet dye has been shown to be 100% sensitive to both Gram-positive and Gram-negative bacterial isolates. Although safranin also had high sensitivity (100%) to S. aureus isolates, its sensitivity to P. aeruginosa was only 20%. Staphylococcus aureus was more resistant to iodine (40% sensitivity) compared to P. aeruginosa, which was 100% sensitive to iodine.

Conclusions: Gentian violet and safranin are low-cost and better tolerated topical agents that have potential for use in dermatological applications. Gentian violet had good antibacterial activity against both Gram-positive and Gram-negative bacteria, making it useful for treating bacterial skin pathogens such as S. aureus and P. aeruginosa especially for MDR bacteria. While safranin has good efficacy against Gram-positive bacteria (S. aureus), its effect against Gram-negative bacteria (e.g. P. aeruginosa) is poor.

背景:许多细菌病原体对抗生素措施的耐药性日益增加,迫切需要新的或重新利用的治疗策略。龙胆紫是一种三芳基甲烷染料,用作组织学染色剂和革兰氏细菌分类方法。它还对某些病原体具有抗菌作用,特别是皮肤感染。由于其低成本和安全的实验室使用,Safranin是医学实验室中最受欢迎的反染剂。然而,对红花素抗菌活性的研究很少。目的:随着多重耐药细菌的日益流行,本研究旨在评价龙胆紫和红花苷对多重耐药金黄色葡萄球菌(S. aureus)和铜绿假单胞菌(P. aeruginosa)的抗菌效果。方法:所有检测细菌均为从皮肤感染(脓肿和伤口)中分离的耐多药(MDR)细菌。以龙胆紫和红花红素为原料,采用孔扩散法对临床分离的20株细菌进行抑菌效果研究,其中10株为金黄色葡萄球菌,10株为铜绿假单胞菌。细菌诊断使用VITEK 2自动系统(biomaemrieux, Marcy-l'Étoile,法国)。碘作为控制剂,因为革兰氏阳性和革兰氏阴性细菌都对它敏感。结果:龙胆紫染料对革兰氏阳性菌和革兰氏阴性菌均100%敏感。红花素对金黄色葡萄球菌也有很高的敏感性(100%),但对铜绿假单胞菌的敏感性仅为20%。金黄色葡萄球菌对碘的抗性更强(敏感性为40%),而铜绿假单胞菌对碘的敏感性为100%。结论:龙胆紫和红花素是一种低成本、耐受性较好的外用药物,具有潜在的皮肤病应用价值。龙胆紫对革兰氏阳性菌和革兰氏阴性菌均有良好的抑菌活性,可用于治疗金黄色葡萄球菌和铜绿假单胞菌等细菌性皮肤病原体,特别是耐多药耐药菌。虽然红花素对革兰氏阳性菌(金黄色葡萄球菌)有良好的疗效,但对革兰氏阴性菌(如铜绿假单胞菌)的效果较差。
{"title":"The Antibacterial Action of Safranin and Gentian Violet.","authors":"Falah Al-Khikani,&nbsp;Aalae Ayit","doi":"10.5041/RMMJ.10475","DOIUrl":"https://doi.org/10.5041/RMMJ.10475","url":null,"abstract":"<p><strong>Background: </strong>The increasing resistance of many bacterial pathogens against antibiotic measures urgently requires new or repurposing therapeutic strategies. Gentian violet is a triarylmethane dye used as a histological stain and for Gram's method of classifying bacteria. It also exerts an antimicrobial effect against certain pathogens, especially dermatological infections. Safranin is the most popular counterstain used in medical laboratories due to its low cost and safe laboratory usage. However, few studies have been conducted on the antimicrobial activity of safranin.</p><p><strong>Objective: </strong>With the growing prevalence of multidrug-resistant bacteria, this study aimed to evaluate the antibacterial efficacy of gentian violet and safranin against multidrug-resistant Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa).</p><p><strong>Methods: </strong>All tested bacteria were multidrug-resistant (MDR) bacteria isolated from skin infections (abscesses and wounds). Using gentian violet and safranin, antibacterial effects were studied using the well-diffusion method against 20 samples of clinically isolated bacteria, 10 diagnosed as S. aureus, and 10 as P. aeruginosa. Bacteria were diagnosed using the VITEK 2 automated system (bioMérieux, Marcy-l'Étoile, France). Iodine served as the control agent, since both Gram-positive and Gram-negative bacteria are sensitive to it.</p><p><strong>Results: </strong>Gentian violet dye has been shown to be 100% sensitive to both Gram-positive and Gram-negative bacterial isolates. Although safranin also had high sensitivity (100%) to S. aureus isolates, its sensitivity to P. aeruginosa was only 20%. Staphylococcus aureus was more resistant to iodine (40% sensitivity) compared to P. aeruginosa, which was 100% sensitive to iodine.</p><p><strong>Conclusions: </strong>Gentian violet and safranin are low-cost and better tolerated topical agents that have potential for use in dermatological applications. Gentian violet had good antibacterial activity against both Gram-positive and Gram-negative bacteria, making it useful for treating bacterial skin pathogens such as S. aureus and P. aeruginosa especially for MDR bacteria. While safranin has good efficacy against Gram-positive bacteria (S. aureus), its effect against Gram-negative bacteria (e.g. P. aeruginosa) is poor.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40688917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Postoperative Pain Control by Local Infiltration Analgesia and Peripheral Nerve Block in Primary Prosthetic Total Knee Arthroplasty. 一期人工全膝关节置换术中局部浸润镇痛和周围神经阻滞对术后疼痛的控制。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-31 DOI: 10.5041/RMMJ.10476
Alexey Vladimirovich Lychagin, Andrey Anatolyevich Gritsyuk, Nahum Rosenberg

Background and objective: Postoperative (post-op) pain control has an important impact on post-op rehabilitation. The logistics of its maintenance challenge the effect of peripheral nerve block on post-op pain control, with the risk for post-op complications. We hypothesized that perioperative use of local infiltration analgesia (LIA) is comparable to post-op pain control by peripheral nerve block.

Materials and methods: We evaluated three groups of patients treated with primary total knee arthroplasty (TKA) due to symptomatic end-stage osteoarthritis with post-op pain control by LIA (LIA group, n=52), femoral plus sciatic nerve block (FSNB) (FSNB group, n=54), and without local or regional analgesia as controls (Control group, n=53). The primary outcome variable was the post-op pain level intensity as measured by the visual analog scale (VAS). Secondary outcome variables were knee function measured by the Knee Society Score (KSS) and the quadriceps muscle strength recovery profile.

Results: Up to 4 hours post-op, pain intensity was significantly lower in FSNB patients (P<0.05). This effect of the peripheral nerve block on the pain level disappeared 6 hours post-op. The LIA and FSNB patients showed a significant decrease in pain intensity on days 2 and 3 post-op (P<0.05) with no mutual differences (P>0.05). This effect disappeared on day 4 post-op (P>0.05). The KSS score showed similar significant improvement of functional abilities (P<0.001) in all three groups. There was no difference in KSS scores among the groups 6 months after surgery (P>0.05). Quadriceps muscle recovery profile was similar in the LIA and Control groups, but significantly poorer in the FSNB group (P<0.001).

Conclusion: The value of very short-term and improved pain relief of post-op FSNB over LIA of the surgical wound should be carefully weighed against its cost, logistics, and potential complication threat.

背景与目的:术后疼痛控制对术后康复有重要影响。其维持的后勤挑战了周围神经阻滞对术后疼痛控制的影响,并存在术后并发症的风险。我们假设围手术期使用局部浸润镇痛(LIA)与周围神经阻滞术后疼痛控制相当。材料和方法:我们评估了三组因症状性终末期骨关节炎而接受原发性全膝关节置换术(TKA)治疗的患者,术后疼痛由LIA (LIA组,n=52)、股骨+坐骨神经阻滞(FSNB组,n=54)和不使用局部或局部镇痛作为对照(对照组,n=53)。主要结局变量是通过视觉模拟量表(VAS)测量的术后疼痛水平强度。次要结局变量是膝关节社会评分(KSS)测量的膝关节功能和股四头肌力量恢复情况。结果:术后4 h, FSNB患者疼痛强度明显降低(P0.05)。这种影响在术后第4天消失(P>0.05)。KSS评分差异有统计学意义(P0.05)。股四头肌恢复情况在LIA组和对照组相似,但FSNB组明显较差(p结论:术后FSNB相对于LIA的短期和改善疼痛缓解的价值应仔细权衡其成本、后勤和潜在的并发症威胁。
{"title":"Postoperative Pain Control by Local Infiltration Analgesia and Peripheral Nerve Block in Primary Prosthetic Total Knee Arthroplasty.","authors":"Alexey Vladimirovich Lychagin,&nbsp;Andrey Anatolyevich Gritsyuk,&nbsp;Nahum Rosenberg","doi":"10.5041/RMMJ.10476","DOIUrl":"https://doi.org/10.5041/RMMJ.10476","url":null,"abstract":"<p><strong>Background and objective: </strong>Postoperative (post-op) pain control has an important impact on post-op rehabilitation. The logistics of its maintenance challenge the effect of peripheral nerve block on post-op pain control, with the risk for post-op complications. We hypothesized that perioperative use of local infiltration analgesia (LIA) is comparable to post-op pain control by peripheral nerve block.</p><p><strong>Materials and methods: </strong>We evaluated three groups of patients treated with primary total knee arthroplasty (TKA) due to symptomatic end-stage osteoarthritis with post-op pain control by LIA (LIA group, n=52), femoral plus sciatic nerve block (FSNB) (FSNB group, n=54), and without local or regional analgesia as controls (Control group, n=53). The primary outcome variable was the post-op pain level intensity as measured by the visual analog scale (VAS). Secondary outcome variables were knee function measured by the Knee Society Score (KSS) and the quadriceps muscle strength recovery profile.</p><p><strong>Results: </strong>Up to 4 hours post-op, pain intensity was significantly lower in FSNB patients (P<0.05). This effect of the peripheral nerve block on the pain level disappeared 6 hours post-op. The LIA and FSNB patients showed a significant decrease in pain intensity on days 2 and 3 post-op (P<0.05) with no mutual differences (P>0.05). This effect disappeared on day 4 post-op (P>0.05). The KSS score showed similar significant improvement of functional abilities (P<0.001) in all three groups. There was no difference in KSS scores among the groups 6 months after surgery (P>0.05). Quadriceps muscle recovery profile was similar in the LIA and Control groups, but significantly poorer in the FSNB group (P<0.001).</p><p><strong>Conclusion: </strong>The value of very short-term and improved pain relief of post-op FSNB over LIA of the surgical wound should be carefully weighed against its cost, logistics, and potential complication threat.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40578106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Quality Assurance of Undergraduate Medical Education in Israel by Continuous Monitoring and Prioritization of the Accreditation Standards. 通过持续监测和确定认证标准的优先顺序来保证以色列本科医学教育的质量。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-07-31 DOI: 10.5041/RMMJ.10480
Jochanan Benbassat, Reuben Baumal, Robert Cohen

External accreditation reviews of undergraduate medical curricula play an important role in their quality assurance. However, these reviews occur only at 4-10-year intervals and are not optimal for the immediate identification of problems related to teaching. Therefore, the Standards of Medical Education in Israel require medical schools to engage in continuous, ongoing monitoring of their teaching programs for compliance with accreditation standards. In this paper, we propose the following: (1) this monitoring be assigned to independent medical education units (MEUs), rather than to an infrastructure of the dean's office, and such MEUs to be part of the school governance and draw their authority from university institutions; and (2) the differences in the importance of the accreditation standards be addressed by discerning between the "most important" standards that have been shown to improve student well-being and/or patient health outcomes; "important" standards associated with student learning and/or performance; "possibly important" standards with face validity or conflicting evidence for validity; and "least important" standards that may lead to undesirable consequences. According to this proposal, MEUs will evolve into entities dedicated to ongoing monitoring of the education program for compliance with accreditation standards, with an authority to implement interventions. Hopefully, this will provide MEUs and faculty with the common purpose of meeting accreditation requirements, and an agreed-upon prioritization of accreditation standards will improve their communication and recommendations to faculty.

本科医学课程的外部认证审查在其质量保证方面发挥着重要作用。然而,这些审查每隔4-10年进行一次,并不是立即发现与教学有关的问题的最佳选择。因此,《以色列医学教育标准》要求医学院对其教学方案进行持续、持续的监测,以确保符合认证标准。在本文中,我们提出以下建议:(1)将这种监测分配给独立的医学教育单位(meu),而不是院长办公室的基础设施,这些meu应成为学校治理的一部分,并从大学机构获得权力;(2)通过区分已被证明可以改善学生福祉和/或患者健康结果的“最重要”标准来解决认证标准重要性的差异;与学生学习及/或表现有关的“重要”标准;“可能重要”的标准具有表面效度或与效度证据相矛盾的标准;以及可能导致不良后果的“最不重要”标准。根据该提案,meu将演变为致力于持续监测教育计划是否符合认证标准的实体,并有权实施干预措施。希望这将为meu和教师提供满足认证要求的共同目标,并且商定的认证标准优先级将改善他们与教师的沟通和建议。
{"title":"Quality Assurance of Undergraduate Medical Education in Israel by Continuous Monitoring and Prioritization of the Accreditation Standards.","authors":"Jochanan Benbassat,&nbsp;Reuben Baumal,&nbsp;Robert Cohen","doi":"10.5041/RMMJ.10480","DOIUrl":"https://doi.org/10.5041/RMMJ.10480","url":null,"abstract":"<p><p>External accreditation reviews of undergraduate medical curricula play an important role in their quality assurance. However, these reviews occur only at 4-10-year intervals and are not optimal for the immediate identification of problems related to teaching. Therefore, the Standards of Medical Education in Israel require medical schools to engage in continuous, ongoing monitoring of their teaching programs for compliance with accreditation standards. In this paper, we propose the following: (1) this monitoring be assigned to independent medical education units (MEUs), rather than to an infrastructure of the dean's office, and such MEUs to be part of the school governance and draw their authority from university institutions; and (2) the differences in the importance of the accreditation standards be addressed by discerning between the \"most important\" standards that have been shown to improve student well-being and/or patient health outcomes; \"important\" standards associated with student learning and/or performance; \"possibly important\" standards with face validity or conflicting evidence for validity; and \"least important\" standards that may lead to undesirable consequences. According to this proposal, MEUs will evolve into entities dedicated to ongoing monitoring of the education program for compliance with accreditation standards, with an authority to implement interventions. Hopefully, this will provide MEUs and faculty with the common purpose of meeting accreditation requirements, and an agreed-upon prioritization of accreditation standards will improve their communication and recommendations to faculty.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40688915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures 骨质疏松性骨折患者抗骨质疏松药物二级预防利用率
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-06-12 DOI: 10.5041/RMMJ.10473
C. Aypak, Mustafa Bircan, Ayşe Özdemir
Objectives Anti-osteoporotic drugs (AOD) are essential for secondary prevention of osteoporotic fracture (OF) in patients with established osteoporosis. However, data about AOD utilization rates are scarce among patients with OF. This study was therefore aimed at determining the AOD utilization rates among those particularly vulnerable patients. Materials and Methods This cross-sectional study followed the medical records of patients with OF starting from their first OF diagnosis date. Each patient’s preventive osteoporosis treatments (vitamin D, calcium+vitamin D) and AOD utilization rate were recorded for a 12-month period following OF diagnosis. Results A total of 210 patients (168 females, mean age: 67.8±11.9 years; 42 males, mean age 62.4±16.1 years) were enrolled in the study. Of these, 65.7% (n=138) did not use any medication for primary protection against osteoporosis before OF diagnosis. The ratio of patients not using any type of medication for secondary prevention after OF increased from 26.5% to 51% during a 12-month period. In addition, by one year following diagnosis, AOD usage rate had decreased from 62.3% to 41.3%. Conclusion The AOD usage rates for secondary prevention of OF were insufficient, and cessation rates were high. Identification of factors associated with decreased AOD utility rates will provide important information for guiding patient follow-up in order to reduce the occurrence of OF.
目的抗骨质疏松药物(AOD)对骨质疏松症患者骨质疏松性骨折(of)的二级预防至关重要。然而,在OF患者中,关于AOD利用率的数据很少。因此,本研究旨在确定那些特别脆弱的患者的AOD利用率。材料和方法这项横断面研究从of患者的第一次诊断日期开始跟踪他们的医疗记录。在OF诊断后的12个月内,记录每位患者的预防性骨质疏松症治疗(维生素D、钙+维生素D)和AOD利用率。结果共有210名患者(168名女性,平均年龄:67.8±11.9岁;42名男性,平均年龄62.4±16.1岁)被纳入研究。其中,65.7%(n=138)在Of诊断前未使用任何药物进行骨质疏松症的初级预防。在12个月的时间里,of后不使用任何类型药物进行二次预防的患者比例从26.5%增加到51%。此外,到确诊后一年,AOD的使用率从62.3%下降到41.3%。结论AOD在of二级预防中的使用率不足,停用率高。识别与AOD使用率下降相关的因素将为指导患者随访以减少of的发生提供重要信息。
{"title":"Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures","authors":"C. Aypak, Mustafa Bircan, Ayşe Özdemir","doi":"10.5041/RMMJ.10473","DOIUrl":"https://doi.org/10.5041/RMMJ.10473","url":null,"abstract":"Objectives Anti-osteoporotic drugs (AOD) are essential for secondary prevention of osteoporotic fracture (OF) in patients with established osteoporosis. However, data about AOD utilization rates are scarce among patients with OF. This study was therefore aimed at determining the AOD utilization rates among those particularly vulnerable patients. Materials and Methods This cross-sectional study followed the medical records of patients with OF starting from their first OF diagnosis date. Each patient’s preventive osteoporosis treatments (vitamin D, calcium+vitamin D) and AOD utilization rate were recorded for a 12-month period following OF diagnosis. Results A total of 210 patients (168 females, mean age: 67.8±11.9 years; 42 males, mean age 62.4±16.1 years) were enrolled in the study. Of these, 65.7% (n=138) did not use any medication for primary protection against osteoporosis before OF diagnosis. The ratio of patients not using any type of medication for secondary prevention after OF increased from 26.5% to 51% during a 12-month period. In addition, by one year following diagnosis, AOD usage rate had decreased from 62.3% to 41.3%. Conclusion The AOD usage rates for secondary prevention of OF were insufficient, and cessation rates were high. Identification of factors associated with decreased AOD utility rates will provide important information for guiding patient follow-up in order to reduce the occurrence of OF.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43129072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
COVID-19: Healthcare Workers May Be at Greater Risk Outside Their Work Environment—A Retrospective Observational Study COVID-19:医务工作者在工作环境之外可能面临更大的风险——回顾性观察研究
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-04-01 DOI: 10.5041/RMMJ.10469
K. Hussein, Y. Shachor-Meyouhas, H. Dabaja-Younis, Moran Szwarcwort-Cohen, J. Tarabeia, A. Weissman, M. Mekel, G. Hyams, M. Halberthal
Background With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary medical center before first BNT162b2 vaccination. Methods This was a retrospective observational study. Before vaccination, HCW at our center were offered serological testing. Data on their epidemiological, workplace, and quarantine history were collected. The SARS-CoV-2 IgG assay was performed pre-vaccination. Results A total of 4,519 (82.5%) of the HCW were tested. Of these, 210 were seropositive; 101 had no known history of COVID-19. Of the 101 asymptomatic HCW, only 3 (3%) had worked at COVID-19 departments, and 70 (69.3%) had not been previously quarantined. Positive serology was similarly distributed across age groups, and about 40% had no children. Nearly half of the HCW tested were administrative and service staff. Overall, seropositive tests were associated with having no children (OR 1.42, 95% CI 1.06–1.89; P=0.0218), history of having been quarantined without proof of disease (OR 6.04, 95% CI 4.55–8.01; P<0.001), and Arab ethnicity (OR 3.36, 95% CI 2.54–4.43; P<0.001). Seropositivity was also more prevalent in members of the administration compared to other sectors, medical and paramedical, who are exposed to patients in their daily work (OR 1.365, 95% CI 1.02–1.82; P=0.04). Conclusions The low percentage of asymptomatic COVID-19 among our HCW may reflect the high compliance to personal protective equipment use despite treating hundreds of COVID-19 patients. The relatively high number of childless seropositive HCW could reflect misconceptions regarding children as a main source of infection, leading to carelessness regarding the need for appropriate out-of-hospital protection.
随着2019冠状病毒病(COVID-19)疫苗的可用性,人们对卫生保健工作者(HCW)疫苗接种前的血清阳性率提出了关注。本研究在以色列三级医疗中心首次接种BNT162b2疫苗前检测HCW的血清阳性率。方法回顾性观察性研究。接种前,本中心对HCW进行血清学检测。收集了他们的流行病学、工作场所和检疫史数据。接种前进行SARS-CoV-2 IgG检测。结果共检出4519例(82.5%)HCW。其中,210例血清阳性;101人没有已知的COVID-19病史。101例无症状感染者中,仅有3例(3%)曾在新冠科室工作,70例(69.3%)未被隔离。血清学阳性在各年龄组的分布相似,约40%没有孩子。近一半的HCW测试是行政和服务人员。总体而言,血清检测阳性与无子女相关(OR 1.42, 95% CI 1.06-1.89;P=0.0218)、无疾病证明的隔离史(OR 6.04, 95% CI 4.55-8.01;P<0.001),阿拉伯民族(OR 3.36, 95% CI 2.54-4.43;P < 0.001)。与在日常工作中与患者接触的其他部门、医疗和辅助医疗部门相比,行政部门成员的血清阳性反应也更为普遍(OR 1.365, 95% CI 1.02-1.82;P = 0.04)。结论我市医护人员无症状感染者比例较低,可能反映了我市在收治数百例新冠肺炎患者的情况下,对个人防护装备的使用依从性较高。无子女的HCW血清学阳性人数相对较高,可能反映了将儿童视为主要感染源的误解,导致对适当的院外保护的必要性的粗心大意。
{"title":"COVID-19: Healthcare Workers May Be at Greater Risk Outside Their Work Environment—A Retrospective Observational Study","authors":"K. Hussein, Y. Shachor-Meyouhas, H. Dabaja-Younis, Moran Szwarcwort-Cohen, J. Tarabeia, A. Weissman, M. Mekel, G. Hyams, M. Halberthal","doi":"10.5041/RMMJ.10469","DOIUrl":"https://doi.org/10.5041/RMMJ.10469","url":null,"abstract":"Background With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary medical center before first BNT162b2 vaccination. Methods This was a retrospective observational study. Before vaccination, HCW at our center were offered serological testing. Data on their epidemiological, workplace, and quarantine history were collected. The SARS-CoV-2 IgG assay was performed pre-vaccination. Results A total of 4,519 (82.5%) of the HCW were tested. Of these, 210 were seropositive; 101 had no known history of COVID-19. Of the 101 asymptomatic HCW, only 3 (3%) had worked at COVID-19 departments, and 70 (69.3%) had not been previously quarantined. Positive serology was similarly distributed across age groups, and about 40% had no children. Nearly half of the HCW tested were administrative and service staff. Overall, seropositive tests were associated with having no children (OR 1.42, 95% CI 1.06–1.89; P=0.0218), history of having been quarantined without proof of disease (OR 6.04, 95% CI 4.55–8.01; P<0.001), and Arab ethnicity (OR 3.36, 95% CI 2.54–4.43; P<0.001). Seropositivity was also more prevalent in members of the administration compared to other sectors, medical and paramedical, who are exposed to patients in their daily work (OR 1.365, 95% CI 1.02–1.82; P=0.04). Conclusions The low percentage of asymptomatic COVID-19 among our HCW may reflect the high compliance to personal protective equipment use despite treating hundreds of COVID-19 patients. The relatively high number of childless seropositive HCW could reflect misconceptions regarding children as a main source of infection, leading to carelessness regarding the need for appropriate out-of-hospital protection.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42873598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients 乳腺癌症患者PET-CT扫描发现的同步性恶性肿瘤
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-04-01 DOI: 10.5041/RMMJ.10472
M. Paran, K. Shulman, B. Kessel, Jasmin Dagan
Breast cancer is a common malignancy and a common cause of cancer-related mortality in women. Pre-treatment workup of breast cancer does not routinely include positron emission tomography scans. We aimed to review cases of women with breast cancer and a synchronous second primary malignancy. We present three cases of women with non-metastatic cancer in whom a synchronous second primary malignancy was found. Synchronous, second primary malignancies which were identified included rectal cancer, gastrointestinal stromal tumor, and non-small cell lung cancer. All second primary malignancies were identified by a PET-CT scan. In conclusion, PET-CT may be used for detection of secondary primary malignancies in select breast cancer patients.
癌症是一种常见的恶性肿瘤,也是女性癌症相关死亡率的常见原因。癌症的治疗前检查不包括正电子发射断层扫描。我们的目的是回顾癌症和同步的第二原发性恶性肿瘤的妇女的病例。我们报告了三例患有非味觉癌症的女性,发现了同步的第二原发性恶性肿瘤。同时发现的第二原发性恶性肿瘤包括直肠癌症、胃肠道间质瘤和癌症非小细胞肺癌。所有第二原发性恶性肿瘤均通过PET-CT扫描确定。总之,PET-CT可用于某些癌症患者的继发原发性恶性肿瘤的检测。
{"title":"Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients","authors":"M. Paran, K. Shulman, B. Kessel, Jasmin Dagan","doi":"10.5041/RMMJ.10472","DOIUrl":"https://doi.org/10.5041/RMMJ.10472","url":null,"abstract":"Breast cancer is a common malignancy and a common cause of cancer-related mortality in women. Pre-treatment workup of breast cancer does not routinely include positron emission tomography scans. We aimed to review cases of women with breast cancer and a synchronous second primary malignancy. We present three cases of women with non-metastatic cancer in whom a synchronous second primary malignancy was found. Synchronous, second primary malignancies which were identified included rectal cancer, gastrointestinal stromal tumor, and non-small cell lung cancer. All second primary malignancies were identified by a PET-CT scan. In conclusion, PET-CT may be used for detection of secondary primary malignancies in select breast cancer patients.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48933852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population-level Outcomes of Early Thyroid Cancers: A Need to Revisit Current Practice 早期甲状腺癌的人群水平结果:需要重新审视当前的做法
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-04-01 DOI: 10.5041/RMMJ.10467
P. Chaturvedi, A. Singh, A. Bhattacharjee, V. Tuljapurkar, D. Nair, D. Chaukar, R. Dikshit
Background Early thyroid cancers have excellent long-term outcomes, yet the word “cancer” draws unnecessary apprehension. This study aimed to define when the recommendations for observation and surveillance may be extended to early thyroid cancers at the population level. Methods Non-metastasized thyroid cancers ≤40 mm diameter were identified from the 1975–2016 Surveillance, Epidemiology and End Results (SEER) database. Causes of death were compared across demographic data. Disease-specific outcomes were compared to the age-adjusted healthy United States (US) population. Survival estimates were computed using Kaplan–Meier and compared using the Cox proportional hazard model. Dynamic benchmarks impacting disease-specific overall survival were determined by decision tree modeling and tested by the Cox model. Results Of the 28,728 thyroid cancers included in this study, 98.4% underwent some form of thyroid-specific treatment and were followed for a maximum of 10.9 years. This group had a 4.3% mortality rate at the end of follow-up (10.9 years maximum), with 13 times more deaths attributed to competing risks rather than thyroid cancer (stage T1a versus stage T1b, P=1.000; T1 versus T2, P<0.001). Among the untreated T1a or T1b tumors, the risk of disease-specific death was 21 times lower than death due to other causes. There was no significant difference between T1a and T1b tumors nor across sex. The age-adjusted risk of death for the healthy US population was higher than for the population with thyroid cancer. Dynamic categorization demonstrated worsening outcomes up to 73 years, uninfluenced by sex or tumor size. For patients over 73 years of age, only tumors >26 mm impacted outcomes. Conclusion Based on the current data, T1a and T1b nodules have similar survival outcomes and are not significantly impacted even when left untreated. Multi-institutional prospective studies are needed to confirm these findings so that current observation and surveillance recommendations can be extended to certain T1 thyroid nodules.
背景:早期甲状腺癌具有良好的长期预后,然而“癌症”一词引起了不必要的担忧。本研究旨在确定观察和监测的建议何时可以扩展到人群水平的早期甲状腺癌。方法从1975-2016年监测、流行病学和最终结果(SEER)数据库中确定直径≤40 mm的非转移性甲状腺癌。通过人口统计数据对死亡原因进行比较。将疾病特异性结果与年龄调整后的健康美国人群进行比较。生存估计使用Kaplan-Meier计算,并使用Cox比例风险模型进行比较。通过决策树模型确定影响疾病特异性总体生存的动态基准,并通过Cox模型进行测试。结果在本研究纳入的28,728例甲状腺癌中,98.4%的患者接受了某种形式的甲状腺特异性治疗,随访时间最长为10.9年。在随访结束时,该组的死亡率为4.3%(最长10.9年),由于竞争风险而不是甲状腺癌导致的死亡多出13倍(T1a期与T1b期,P=1.000;T1与T2相比,P26 mm影响预后。根据目前的数据,T1a和T1b结节具有相似的生存结局,即使不治疗也没有明显影响。需要多机构的前瞻性研究来证实这些发现,以便目前的观察和监测建议可以扩展到某些T1甲状腺结节。
{"title":"Population-level Outcomes of Early Thyroid Cancers: A Need to Revisit Current Practice","authors":"P. Chaturvedi, A. Singh, A. Bhattacharjee, V. Tuljapurkar, D. Nair, D. Chaukar, R. Dikshit","doi":"10.5041/RMMJ.10467","DOIUrl":"https://doi.org/10.5041/RMMJ.10467","url":null,"abstract":"Background Early thyroid cancers have excellent long-term outcomes, yet the word “cancer” draws unnecessary apprehension. This study aimed to define when the recommendations for observation and surveillance may be extended to early thyroid cancers at the population level. Methods Non-metastasized thyroid cancers ≤40 mm diameter were identified from the 1975–2016 Surveillance, Epidemiology and End Results (SEER) database. Causes of death were compared across demographic data. Disease-specific outcomes were compared to the age-adjusted healthy United States (US) population. Survival estimates were computed using Kaplan–Meier and compared using the Cox proportional hazard model. Dynamic benchmarks impacting disease-specific overall survival were determined by decision tree modeling and tested by the Cox model. Results Of the 28,728 thyroid cancers included in this study, 98.4% underwent some form of thyroid-specific treatment and were followed for a maximum of 10.9 years. This group had a 4.3% mortality rate at the end of follow-up (10.9 years maximum), with 13 times more deaths attributed to competing risks rather than thyroid cancer (stage T1a versus stage T1b, P=1.000; T1 versus T2, P<0.001). Among the untreated T1a or T1b tumors, the risk of disease-specific death was 21 times lower than death due to other causes. There was no significant difference between T1a and T1b tumors nor across sex. The age-adjusted risk of death for the healthy US population was higher than for the population with thyroid cancer. Dynamic categorization demonstrated worsening outcomes up to 73 years, uninfluenced by sex or tumor size. For patients over 73 years of age, only tumors >26 mm impacted outcomes. Conclusion Based on the current data, T1a and T1b nodules have similar survival outcomes and are not significantly impacted even when left untreated. Multi-institutional prospective studies are needed to confirm these findings so that current observation and surveillance recommendations can be extended to certain T1 thyroid nodules.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43901564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Fasting Insulin Level, Homeostatic Model of Insulin Resistance, and Lipid Levels between Patients with Primary Hypertension and Normotensive Subjects 原发性高血压患者与正常人空腹胰岛素水平、胰岛素抵抗稳态模型及脂质水平的比较
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-04-01 DOI: 10.5041/RMMJ.10468
Rithvik Ramesh, Viswanathan Pandurangan, Sudha Madhavan, D. Srinivasan, E. Bhaskar, Lakshmi Marappa, Aiswarya M Nair, Vaasanthi Rajendran, Priyadarshini Varadaraj
Background Hyperinsulinemia and insulin resistance occurs in obese patients with primary hypertension independent of diabetes and obesity. This study was aimed at assessing serum fasting insulin levels, the homeostatic model assessment for insulin resistance (HOMA-IR), and serum lipid levels in non-obese patients with primary hypertension when compared to normotensive subjects. Methods This observational study comprised 100 patients over 18 years of age, divided into two groups. The hypertensive group comprised non-obese patients with primary hypertension (n=50); the normotensive group comprised normotensive age- and sex-matched individuals (n=50). Patients with diabetes, impaired fasting glucose, obesity, and other causative factors of insulin resistance were excluded from the study. Serum fasting insulin levels and fasting lipid profiles were measured, and insulin resistance was calculated using HOMA-IR. These data were compared between the two groups. Pearson’s correlation coefficient was used to assess the extent of a linear relationship between HOMA-IR and to evaluate the association between HOMA-IR and systolic and diastolic blood pressures. Results Mean serum fasting insulin levels (mIU/L), mean HOMA-IR values, and fasting triglyceride levels (mg/dL) were significantly higher in the hypertensive versus normotensive patients (10.32 versus 6.46, P<0.001; 1.35 versus 0.84, P<0.001; 113.70 versus 97.04, P=0.005, respectively). The HOMA-IR levels were associated with systolic blood pressure (r value 0.764, P=0.0005). Conclusion We observed significantly higher fasting insulin levels, serum triglyceride levels, and HOMA-IR reflecting hyperinsulinemia and possibly an insulin-resistant state among primary hypertension patients with no other causally linked factors for insulin resistance. We observed a significant correlation between systolic blood pressure and HOMA-IR.
背景:高胰岛素血症和胰岛素抵抗发生在与糖尿病和肥胖无关的肥胖原发性高血压患者中。本研究旨在评估非肥胖原发性高血压患者与正常高血压患者的空腹胰岛素水平、胰岛素抵抗稳态模型评估(HOMA-IR)和血脂水平。方法观察性研究纳入100例18岁以上患者,随机分为两组。高血压组为非肥胖原发性高血压患者(n=50);正常血压组由年龄和性别匹配的正常血压个体组成(n=50)。伴有糖尿病、空腹血糖受损、肥胖和其他胰岛素抵抗因素的患者被排除在研究之外。测定空腹血清胰岛素水平和空腹血脂,并用HOMA-IR计算胰岛素抵抗。将这些数据在两组之间进行比较。Pearson相关系数用于评估HOMA-IR之间的线性关系程度,以及评估HOMA-IR与收缩压和舒张压之间的关系。结果高血压患者的平均空腹血清胰岛素水平(mIU/L)、平均HOMA-IR值和空腹甘油三酯水平(mg/dL)显著高于正常高血压患者(10.32比6.46,P<0.001;1.35 vs 0.84, P<0.001;113.70 vs 97.04, P=0.005)。HOMA-IR水平与收缩压相关(r值0.764,P=0.0005)。结论:我们观察到原发性高血压患者空腹胰岛素水平、血清甘油三酯水平和HOMA-IR水平明显升高,反映了高胰岛素血症和可能的胰岛素抵抗状态,没有其他与胰岛素抵抗相关的因果因素。我们观察到收缩压和HOMA-IR之间有显著的相关性。
{"title":"Comparison of Fasting Insulin Level, Homeostatic Model of Insulin Resistance, and Lipid Levels between Patients with Primary Hypertension and Normotensive Subjects","authors":"Rithvik Ramesh, Viswanathan Pandurangan, Sudha Madhavan, D. Srinivasan, E. Bhaskar, Lakshmi Marappa, Aiswarya M Nair, Vaasanthi Rajendran, Priyadarshini Varadaraj","doi":"10.5041/RMMJ.10468","DOIUrl":"https://doi.org/10.5041/RMMJ.10468","url":null,"abstract":"Background Hyperinsulinemia and insulin resistance occurs in obese patients with primary hypertension independent of diabetes and obesity. This study was aimed at assessing serum fasting insulin levels, the homeostatic model assessment for insulin resistance (HOMA-IR), and serum lipid levels in non-obese patients with primary hypertension when compared to normotensive subjects. Methods This observational study comprised 100 patients over 18 years of age, divided into two groups. The hypertensive group comprised non-obese patients with primary hypertension (n=50); the normotensive group comprised normotensive age- and sex-matched individuals (n=50). Patients with diabetes, impaired fasting glucose, obesity, and other causative factors of insulin resistance were excluded from the study. Serum fasting insulin levels and fasting lipid profiles were measured, and insulin resistance was calculated using HOMA-IR. These data were compared between the two groups. Pearson’s correlation coefficient was used to assess the extent of a linear relationship between HOMA-IR and to evaluate the association between HOMA-IR and systolic and diastolic blood pressures. Results Mean serum fasting insulin levels (mIU/L), mean HOMA-IR values, and fasting triglyceride levels (mg/dL) were significantly higher in the hypertensive versus normotensive patients (10.32 versus 6.46, P<0.001; 1.35 versus 0.84, P<0.001; 113.70 versus 97.04, P=0.005, respectively). The HOMA-IR levels were associated with systolic blood pressure (r value 0.764, P=0.0005). Conclusion We observed significantly higher fasting insulin levels, serum triglyceride levels, and HOMA-IR reflecting hyperinsulinemia and possibly an insulin-resistant state among primary hypertension patients with no other causally linked factors for insulin resistance. We observed a significant correlation between systolic blood pressure and HOMA-IR.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48627523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rambam Maimonides Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1